Abstract
A RETROSPECTIVE CROSS-SECTIONAL STUDY TO ANALYZE ADVERSE DRUG REACTIONS REPORTED AT TERTIARY CARE HOSPITAL

Dr. Virendra Kushwaha, *Dr. Pooja Agrawal, Dr. Pushpendra Pushkar, Dr. Tanvi Azmi, Sumit Kumar

ABSTRACT

Objectives: To analyze the pattern and nature of adverse drug reactions (ADRs) reported to ADR monitoring center (AMC) of tertiary care hospital in Kanpur. Materials and Methods: This study is a retrospective cross-sectional analysis of all ADRs reported to AMC, Department of Pharmacology, GSVM Medical College, Kanpur during 12 months duration (July 2018 to June 2019). These ADRs were analyzed for the pattern, system organ class involved, suspected drug/drugs, type of reactions, seriousness and causality assessment. Results: A total of 408 ADRs were reported from 299 patients. The majority of the patients (84.950%) were between 19-60 years with female preponderance (54.515%). As per the WHO-UMC causality assessment system, 84.615% ADRs were probable while 15.385% ADRs were possible and 3 patients (1.003%) suffered from serious ADRs. The gastrointestinal (36.520%) was the most affected system, followed by the nervous system (15.931%), skin & subcutaneous tissue (14.706%), psychiatric (13.971%) and general (10.539%) disorders. The majority of ADRs were of type-A (86.275%) while remaining of type-B (0.490%), type-C (0.490%) and type-F (0.245%). Conclusions: We can prevent these ‘avoidable’ reactions by safe prescribing and enthusiastic participation in pharmacovigilance. The concept of ADR reporting is still new in India and reporting of ADRs is scarce. There is a need for active participation of all the departments of this tertiary care hospital for ADRs reporting. This study warrants further research in the northern part of India for the development of possible intervention strategies so that the burden of ADRs can be reduced.

Keywords: ADR, adverse drug reaction monitoring center, Pharmacovigilance Programme of India, NCC-PvPI, WHO-UMC.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tanima Debnath Sarkar

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2021 Issue has been successfully launched on 1 October 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT